India's Pharma Industry Expects Q4 Earnings Boost from US Market as Exports Surge on Nostr: Indian Drugmakers Expected to See Revenue Boost in the US Market in FY25 Due to Drug ...
Indian Drugmakers Expected to See Revenue Boost in the US Market in FY25 Due to Drug Shortages
===============
#73e045c2 ver:0.18
Indian drugmakers are expected to see a revenue boost in the US market in FY25 due to drug shortages, filling the gap left by US-based manufacturers. The Indian pharmaceutical industry is also anticipating positive Q4 earnings, driven by growth in the US market. Despite regulatory challenges and rising pricing pressures, India's pharmaceutical exports to the US have surged by 15%. Investors are advised to consider pharma, FMCG, and banks for fresh allocations, while caution is advised with overhyped companies. #pharma #USmarket #drugshortages #earnings #investing...
#newstr #IndianDrugmakers #UsMarket #RevenueBoost #DrugShortages #DrReddy's #Cipla #SunPharma
https://here.news/story/73e045c2?ver=0.18
===============
#73e045c2 ver:0.18
Indian drugmakers are expected to see a revenue boost in the US market in FY25 due to drug shortages, filling the gap left by US-based manufacturers. The Indian pharmaceutical industry is also anticipating positive Q4 earnings, driven by growth in the US market. Despite regulatory challenges and rising pricing pressures, India's pharmaceutical exports to the US have surged by 15%. Investors are advised to consider pharma, FMCG, and banks for fresh allocations, while caution is advised with overhyped companies. #pharma #USmarket #drugshortages #earnings #investing...
#newstr #IndianDrugmakers #UsMarket #RevenueBoost #DrugShortages #DrReddy's #Cipla #SunPharma
https://here.news/story/73e045c2?ver=0.18